# Study to Assess the Safety and Efficacy of the IUB SEAD™ Device

> **NCT04381416** · NA · COMPLETED · sponsor: **Ocon Medical Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Abnormal Uterine Bleeding

## Interventions

- **DEVICE:** SEAD treatment

## Key facts

- **NCT ID:** NCT04381416
- **Lead sponsor:** Ocon Medical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04381416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04381416, "Study to Assess the Safety and Efficacy of the IUB SEAD™ Device". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04381416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*